Placebo (two doses): Clinical Trials

2 trials of Placebo (two doses), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Terminated 1

Follow Placebo (two doses): new trials by email Literature Review of Placebo (two doses) trials Research Report on Placebo (two doses)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA
amobarbital/Gel-One (one dose), Placebo (single dose), amobarbital/Gel-One (two doses) - Osteoarthritis, Post-traumatic Osteoarthritis
Phase 1 / Phase 2TerminatedJ L Marsh52022-07-202026-07-06
A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.
Low dose Ebola Zaire vaccine (Ad5-EBOV), High dose Ebola Zaire vaccine (Ad5-EBOV), placebo (one dose) - Ebola Virus Disease
Phase 1CompletedJiangsu Province Centers for Disease Control and Prevention1202014-12-012015-08-28

Conditions studied

Hemorrhagic Fever, Ebola (1)  ·  Osteoarthritis (1)

Sponsors

J L Marsh (1)  ·  Jiangsu Province Centers for Disease Control and Prevention (1)

Countries

China (1)  ·  United States (1)

Results publications

PMID 25817373, PMID 28017642